Global Cord Blood Corporation logo

Global Cord Blood Corporation (CORBF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
0. 95
0
0%
$
127.22M Market Cap
2.14 P/E Ratio
0.32% Div Yield
14,350 Volume
0 Eps
$ 0.95
Previous Close
Add Transaction
Day Range
0.95 0.95
Year Range
0.2 1.75
Want to track CORBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CORBF closed Friday higher at $0.95, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, CORBF stock gained 0%.
CORBF pays dividends to its shareholders, with the most recent payment made on Aug 24, 2018. The next estimated payment will be in 24 Aug 2018 on Aug 24, 2018 for a total of $0.08.
The last earnings report, released on Apr 01, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

CORBF Chart

Global Cord Blood Corporation (CORBF) FAQ

What is the stock price today?

The current price is $0.95.

On which exchange is it traded?

Global Cord Blood Corporation is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CORBF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.32%.

What is its market cap?

As of today, the market cap is 127.22M.

Has Global Cord Blood Corporation ever had a stock split?

No, there has never been a stock split.

Global Cord Blood Corporation Profile

Professional Services Industry
Industrials Sector
Ting Zheng CEO
OTC PINK Exchange
G39342103 CUSIP
HK Country
1,202 Employees
24 Aug 2018 Last Dividend
- Last Split
9 May 2007 IPO Date

Overview

Global Cord Blood Corporation is a specialized healthcare service provider based in Central, Hong Kong, focusing on the collection, testing, processing, and storage of umbilical cord blood. Serving the People's Republic of China, it operates under the auspices of its parent company, Blue Ocean Structure Investment Company Ltd. Initially known as China Cord Blood Corporation, the organization rebranded to its current name in March 2018, signaling a broader scope of operations. As of March 31, 2022, the company has established a strong operational base with three cord blood banks located in the Beijing municipality, Guangdong province, and Zhejiang province. Through these facilities, Global Cord Blood Corporation offers critical biobanking services, contributing to the health and wellbeing of the Chinese population by facilitating the potential future use of stem cells in medical treatments.

Products and Services

  • Cord Blood Testing:

    This service involves comprehensive testing of umbilical cord blood to ensure its viability and safety for long-term storage and future medical applications. It is a crucial step in validating the integrity and utility of cord blood, which may contain life-saving stem cells.

  • Cord Blood Processing:

    The company provides advanced processing services for umbilical cord blood. This process includes cell separation and reduction of plasma volume, which are essential steps in preparing the blood for cryogenic storage, ensuring the preservation of stem cells' functional viability.

  • Cord Blood Storage:

    Following testing and processing, the company offers long-term, cryogenic storage services for the umbilical cord blood in their state-of-the-art facilities. This service ensures that the stem cells remain viable for decades, available for potential therapeutic use in the future.

  • Donated Cord Blood Services:

    Aside from services for individual subscribers, Global Cord Blood Corporation also manages donated cord blood. This involves the testing, processing, and storage of cord blood donated by parents for public use, thus providing a valuable resource for medical research and stem cell transplantation.

  • Matching Services:

    In addition to storage services, the company provides matching services wherein they match stored cord blood units with recipients in need of stem cell transplants. This service is vital for those requiring stem cell treatments, facilitating quicker access to compatible stem cells.

Contact Information

Address: Bank of China Tower
Phone: 852 3605 8180